Skip to content

Controlled Phonation and Vocal Rest Programs After Acute Vocal Exertion in Healthy Adults

Vocal Restoration Programs After Acute Vocal Exertion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03762993
Enrollment
37
Registered
2018-12-04
Start date
2018-12-05
Completion date
2020-07-01
Last updated
2021-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The proposed research will investigate the most effective strategy to reduce vocal exertion reported by speakers in noisy environments. Repeated vocal exertion can lead to voice problems and therefore identifying effective strategies can lead to better prevention of acquired voice disorders. This study will compare the effects of vocal rest and controlled phonation both before and after vocal exertion. The investigators hypothesize that vocal rest and controlled phonation will mitigate the negative effects of vocal exertion.

Interventions

BEHAVIORALVocal rest and Controlled Phonation

Voice rest and semi occluded vocal tract voice exercises

Sponsors

Purdue University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Within Subject Design

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* within age range

Exclusion criteria

* Voice Disorders * Strong gag reflex * Craniofacial disorders * Cognitive Impairments * Head and Neck Cancer * Hearing Difficulties * Dentition problems that prevent an oral scope being placed in mouth

Design outcomes

Primary

MeasureTime frameDescription
Phonation Threshold Pressure2.5 hoursMinimum air pressure required to initiate and sustain vocal fold oscillation

Secondary

MeasureTime frameDescription
Lung Volume Excursion2.5 hoursThe difference between lung volume initiation and termination on connected speech

Countries

United States

Participant flow

Pre-assignment details

Of 37 enrolled participants, 31 were assigned to study groups based on self-reported vocal fatigue level.

Participants by arm

ArmCount
Healthy Adults
Participants will complete vocal rest and controlled phonation Vocal rest and Controlled Phonation: Voice rest and semi occluded vocal tract voice exercises
21
Healthy Adults Reporting Vocal Fatigue
Participants will complete vocal rest and controlled phonation Vocal rest and Controlled Phonation: Voice rest and semi occluded vocal tract voice exercises
10
Total31

Baseline characteristics

CharacteristicHealthy AdultsTotalHealthy Adults Reporting Vocal Fatigue
Age, Categorical
<=18 years
4 Participants8 Participants4 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
17 Participants23 Participants6 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants1 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
21 Participants30 Participants9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants5 Participants2 Participants
Race (NIH/OMB)
Black or African American
3 Participants4 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
15 Participants21 Participants6 Participants
Region of Enrollment
United States
21 participants31 participants10 participants
Sex: Female, Male
Female
11 Participants15 Participants4 Participants
Sex: Female, Male
Male
10 Participants16 Participants6 Participants
Vocal Fatigue Index
Vocal Fatigue Index Part 1
4 units on a scale4 units on a scale24 units on a scale
Vocal Fatigue Index
Vocal Fatigue Index Part 2
0 units on a scale2 units on a scale3.5 units on a scale

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 210 / 10
other
Total, other adverse events
0 / 210 / 10
serious
Total, serious adverse events
0 / 210 / 10

Outcome results

Primary

Phonation Threshold Pressure

Minimum air pressure required to initiate and sustain vocal fold oscillation

Time frame: 2.5 hours

ArmMeasureGroupValue (MEAN)Dispersion
Healthy AdultsPhonation Threshold PressurePre-Exertion5.41 cmH20Standard Deviation 1.26
Healthy AdultsPhonation Threshold PressurePost-Exertion6.39 cmH20Standard Deviation 1.8
Healthy AdultsPhonation Threshold PressurePost Restoration Strategy5.63 cmH20Standard Deviation 1.32
Healthy Adults Reporting Vocal FatiguePhonation Threshold PressurePre-Exertion5.08 cmH20Standard Deviation 1.59
Healthy Adults Reporting Vocal FatiguePhonation Threshold PressurePost-Exertion6.33 cmH20Standard Deviation 1.4
Healthy Adults Reporting Vocal FatiguePhonation Threshold PressurePost Restoration Strategy5.61 cmH20Standard Deviation 1.59
p-value: <0.001Mixed Models Analysis
Secondary

Lung Volume Excursion

The difference between lung volume initiation and termination on connected speech

Time frame: 2.5 hours

ArmMeasureGroupValue (MEAN)Dispersion
Healthy AdultsLung Volume ExcursionBaseline13.5 % Vital CapacityStandard Deviation 7.2
Healthy AdultsLung Volume ExcursionPost Exertion21.6 % Vital CapacityStandard Deviation 10.6
Healthy AdultsLung Volume ExcursionPost Restoration Strategy18.7 % Vital CapacityStandard Deviation 11.5
Healthy Adults Reporting Vocal FatigueLung Volume ExcursionBaseline14.5 % Vital CapacityStandard Deviation 6.4
Healthy Adults Reporting Vocal FatigueLung Volume ExcursionPost Exertion12.9 % Vital CapacityStandard Deviation 6.5
Healthy Adults Reporting Vocal FatigueLung Volume ExcursionPost Restoration Strategy18.4 % Vital CapacityStandard Deviation 7.15
p-value: <0.01Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026